Verition Fund Management
BLFS icon

Verition Fund Management’s BioLife Solutions BLFS Stock Holding History

Verition Fund Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,671
Closed -$433K – 3344
2024
Q4 		$433K Sell
16,671
-2,737
-14% -$68.1K ﹤0.01% 2562
2024
Q3 		$486K Sell
19,408
-2,231
-10% -$52.7K ﹤0.01% 2347
2024
Q2 		$464K Buy
+21,639
New +$420K ﹤0.01% 2091
2021
Q4 		– Sell
-11,303
Closed -$478K – 2546
2021
Q3 		$478K Buy
+11,303
New +$544K ﹤0.01% 1246
2015
Q2 		– Sell
-113,972
Closed -$183K – 619
2015
Q1 		$183K Sell
113,972
-26,153
-19% -$48.9K 0.02% 323
2014
Q4 		$230K Hold
140,125
– – 0.05% 204
2014
Q3 		$294K Sell
140,125
-10
-0% -$24 0.04% 399
2014
Q2 		$320K Buy
+140,135
New +$378K 0.03% 397

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Verition Fund Management's BLFS Position: Q1 2025 in Review

Verition Fund Management sold out of BioLife Solutions (BLFS) in Q1 2025, closing a stake of 16,671 shares — an estimated $433K sold.

Verition Fund Management first reported a position in BLFS in Q2 2014 and held it in 8 quarters. The position peaked at $486K in Q3 2024. 188 funds tracked by Wall St. Rank hold BLFS as of Q1 2025.

  • Verition Fund Management reported no remaining BioLife Solutions position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 16,671 BioLife Solutions shares in Q1 2025, an estimated $433K.
  • Verition Fund Management first reported a position in BioLife Solutions in Q2 2014 and held it in 8 quarters.
  • Verition Fund Management's BioLife Solutions position peaked at $486K in Q3 2024.
  • 188 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.